- Acknowledgements and Disclosures
For helpful comments and suggestions on this paper, we thank Jacob Dorn, Ashvin Gandhi, Toru Kitagawa, Erzo Luttmer, Chuck Manski, Paul Novosad, Ziad Obermeyer, Alex Olssen, Stephen Ryan, Fiona Scott Morton, Sachin Shah, Advik Shreekumar, Jonathan Skinner, Doug Staiger, Mintu Turakhia, Stefan Wager, and Chris Walters. We thank Shubh Lashkary, Elliot Lee, Erick Ore Matos, Simone Pandit, Francis Peng, Jonatas Teixeira Prates, Melinda Xu, Sibo Zhou, Wyatt Zhou, and Jessie Zhu for invaluable research assistance. We are grateful to Diana Zhu for her substantial contributions to that phase of the research. We thank Daniel Singer for his clinical and institutional guidance throughout the project and for connecting us with Carl van Walraven and the Atrial Fibrillation Investigators, who generously shared the AFI database for reanalysis. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.
- Citation and Citation DataCopy Citation Jason Abaluck, Leila Agha, and David C. Chan Jr, "Are Guidelines Worth Following? Decision-Making Under Incomplete Evidence," NBER Working Paper 35798 (2026), https://doi.org/10.3386/w35798. Copy to Clipboard Download Citation
- Associated Links
Are Guidelines Worth Following? Decision-Making Under Incomplete Evidence -- by Jason Abaluck, Leila Agha, David C. Chan Jr
- Published by
- NBER
- Published
- Length
- 188 words · 1 min
Where this came from
This story was reported and first published by NBER on 24 September 2026. HUE Legacy Ventures did not write it.
Carried in full with attribution and a link to the original. Rights remain with the publisher, who may request removal at any time.